Tags: Chemical Compound, Chemical Substance.

Vaniprevir (MK-7009) is a macrocyclic Hepatitis C virus (HCV) NS3/4a protease inhibitor developed by Merck & Co. which is currently in clinical testing.

Vaniprevir.svg
FDA UNII code
CV3X74AO1H
IUPAC name
(1R21S24S)-21-tert-butyl-N-((1R2R)-1-[(cyclopropylsulfonyl)amino]carbonyl-2-ethylcyclopropyl)-1616-dimethyl-31922-trioxo-218-dioxa-42023-triazatetracyclo[21.2.1.147.0611]-heptacosa-6810-triene-24-carboxamide

Loading...

This page contains content from the copyrighted Wikipedia article "Vaniprevir"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.